Robotic vs. laparoscopic Roux-en-Y gastric bypass in patients with BMI ≥ 60 kg/m2 - results of over 230,000 patients using the MBSAQIP database Authors: Kamil Rapacz, Jaroslaw Szymanski, R Armour Forse, Tomasz Rogula Published: 2025 ABSTRACT AbstractBackgroundPatients with a BMI (Body Mass Index) ≥ 60 kg/m2 are at high risk for bariatric surgery. They have higher complication rates, longer length of stay and greater technical difficulties with surgery. Surgical robots offer better ergonomics and precision, which facilitate surgery. The role of the robot in patients with obesity class V (BMI ≥ 60 kg/m2) surgery has not been adequately evaluated.ObjectivesThis study reports data of over 230,000 patients regarding bariatric surgery. We aim to compare the results of laparoscopic and robotic RYGB in patients with BMI ≥ 60 kg/m2.SettingMBSAQIP database.MethodsPatients aged 18–80 years who underwent Roux-en-Y gastric bypass (RYGB) were included using the 2020–2023 MBSAQIP database. We compared the 30-day outcomes of laparoscopic versus robotic RYGB in patients with BMI < 60 kg/m2 versus BMI ≥ 60 kg/m2.ResultsThere are 233,828 patients in this study. Patients with BMI ≥ 60 kg/m2, as compared to BMI < 60 kg/m2, were more likely to have postoperative complications (5,23% vs. 4,44%, p = 0,039), acute renal failure (0,23% vs. 0,07%, p = 0,007), unplanned admission to ICU (1,08% vs. 0,73%, p = 0,029) and Emergency Department visits after discharge (12,38% vs. 11,02%, p = 0,019). There is no difference in 30-day complication rate between laparoscopic and robotic RYGB in patients with BMI ≥ 60 kg/m2.ConclusionsPatients with BMI ≥ 60 kg/m2 have higher rates of complications compared to patients with BMI < 60 kg/m2. RRYGB seems to be a safe to perform in patients with BMI ≥ 60 kg/m2 with no difference in 30-day complication rate, longer average operating time but shorter length of stay. There is still a need for good quality multi-centre prospective research study to define the best approach for patients with obesity class V.Keywords: Bariatric surgery, Robotic surgery, Obesity, RYGB, Roux-en-Y gastric bypass Introduction Obesity in one of the main health problems today. Overweight or obesity in adults exceeded 50% in the majority of countries (147 out of 200) [1]. The American Society for Metabolic and Bariatric Surgery shows that in past 2 years, bariatric procedures increased to over 270,000 procedures annually in the USA [2]. The RYGB as compared to the sleeve gastrectomy offers several advantages, including increased effectiveness at excess weight loss (%EWL), enhanced management of diabetes and gastric reflux, yet has similar and/or lower perioperative risks [3–5]. Nonetheless, managing patients with BMI (Body Mass Index) ≥ 60 kg/m2 presents certain challenges when performing the RYGB. For years, laparoscopy has represented the standard surgical approach; however, the rapid development of robotic surgery is reshaping current practices. Surgical robots have transformed modern minimally invasive surgery facilitating surgical control, vision, and procedural comfort. More than a dozen robotic systems are now available worldwide, with a variety of functions, for example: precise wrist-like movement, motion scaling, tremor filtering, high-resolution 3D vision, or haptic feedback [6, 7]. Robotic surgery is a promising technique in bariatrics, notably in difficult cases and reoperations. Despite its technical advantages, its widespread use is limited by costs and lack of clear evidence of superiority over laparoscopy in standard cases [8–13]. It is well-liked among the bariatric surgeons and appears to be more useful for more advanced procedures such as the RYGB. Based on MBSAQIP database in 2015 only 7% of all RYGB procedures were performed in assistance of robotic platform. The number increases during the years, displacing other methods, with the 18% in 2020 to 39% in 2023 of RYGB being robotic. Patients with obesity class V (BMI ≥ 60 kg/m2) require special care, superior surgical skills and are at even greater risk for complications [14]. Findings indicate that surgical robots my prove beneficial in this group of patients, with greater freedom and precision of movement, less force, better visualization and comfort. There is still no quality data in this field. We aim to compare the 30-day postoperative outcomes and complications for patients with BMI < 60 kg/m2 versus ≥ 60 kg/m2 who underwent laparoscopic Roux-en-Y gastric bypass (LRYGB) or robotic Roux-en-Y gastric bypass (RRYGB) through an analysis of the 2020–2023 MBSAQIP database. Methodology Database source Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) embraces nearly 1000 sites in the US and Canada [2, 15]. The program is dedicated to enhancing the safety and quality of care for bariatric patients. With over 200,000 metabolic and bariatric cases captured each year, the MBSAQIP is one of the largest, bariatric-specific, clinical data sets. The 2020 to 2023 MBSAQIP PUF files were used for the study. The PUF contains patient-level, aggregate data and does not identify hospitals, health care providers, or patients’ sensitive personal data. MBSAQIP-PUF contains over 180 variables including patient characteristics such as age, sex and medical history, procedure details, 30-day complications, reoperations, readmissions and interventions history. All data were collected, audited and combined by two independent investigators. In this study we included patients who underwent either LRYGB or RRYGB and are in the MBSAQIP data registry from January 1, 2020, to December 31, 2023. We merged different files of the participant use file (PUF) by using the individual case identification numbers. Patients who underwent RYGB were identified by the Current Procedural Terminology code 43,644. Patients within the age range 18–80 with a BMI before surgery of over 30 kg/m2 were included. Exclusion criteria included other approaches besides laparoscopic and robotic-assisted RYGB such as open, single incision, hand-assisted and NOTES (natural orifice transluminal endoscopic surgery). MBSAQIP data are deprived of patients’ personal data, not allowing to be identified. De-identified datasets as MBSAQIP do not constitute strictly Human Subjects Research; therefore, the Institute for Research and Development (IRD) of DHR Health Edinburg approved the study exempt status. Data characteristics To characterize the population we used age, sex, ASA score I-V, race and 20 parameters of medical condition: smoking, diabetes, immunosuppression drug usage, COPD (chronic obstructive pulmonary disease), history of pulmonary embolism (PE), sleep apnea, gastroesophageal reflux disease (GERD), previous foregut surgery, previous percutaneous coronary intervention (PCI) or percutaneous transluminal coronary angioplasty (PTCA), previous cardiac surgery, history of heart failure, ventricular assist device (VAD), hypertension, hyperlipidemia, history of deep venous thrombosis (DVT), therapeutic anticoagulation usage, venous stasis, inferior vena cava (IVC) filter, current need for dialysis and renal insufficiency. Surgical outcomes were assessed including 22 parameters occurred at any time within the 30-day: overall perioperative complications, surgical site infection (SSI), anastomosis/staple line leak, wound disruption, pneumonia, unplanned intubation, pulmonary embolism, ventilator-assisted respirations greater than 48 h, progressive renal insufficiency, acute renal failure requiring dialysis, urinary tract infection (UTI), cardiac arrest requiring CPR, blood transfusion, sepsis, unplanned admission to the intensive care unit (ICU), gastrointestinal tract bleeding, bowel obstruction, Emergency Department (ED) visits after the discharge, unplanned readmission, reoperation, interventions and deaths. We also compared average operating time, anastomosis check, drain placement and length of stay (LOS). Statistical analysis Univariate analyses were performed using either the Pearson chi2 test or Fisher’s exact test for categorical variables. For normally distributed continuous variables t-Student test was used as a parametric test and for non-normally distributed continuous variables Mann-Withey U test was used as a nonparametric statistical test. The results are showed as the frequency and percentage for categorical variables and mean (± standard deviation) for continuous variables. The p value < 0.05 was considered statistically significant. All analyses were performed with computer software (IBM SPSS Statistics, Version 29.0.0.0. (241), IBM Corp., Armonk, NY). Results Patient characteristics A total of 233,828 patients met the study inclusion criteria. There were 164,381 included for LRYGB (70,30%) and 69,447 for RRYGB (29,70%), respectively. The characteristics of the groups are shown in Table 1. In first analysis we compared patients who underwent LRYGB (164,315) with RRYGB (69,417) divided into two groups: those with the BMI < 60 kg/m2 (224,174) and those with the BMI ≥ 60 kg/m2 (9,558). We reported 96 excluded data - non-binary patients. Table 1Population characteristics. Comparing patients between LRYGB and RRYGB divided into two groups of BMI < 60 kg/m2 and BMI ≥ 60 kg/m2BMI < 60 kg/m2BMI ≥ 60 kg/m2LRYGB, n = 157,815RRYGB, n = 66,359 p LRYGB, n = 6500RRYGB, n = 3058 p AGE (years) 45,19 ± 11,3645,48 ± 11,38< 0,00140,39 ± 10,4540,39 ± 10,560,885 BMI (kg/m2) 43,84 ± 6,3243,82 ± 6,480,13465,34 ± 5,3865,40 ± 5,430,418 SEX (female) 133,692 (84,71%)56,597 (85,29%)0,0085127 (78,88%)2462 (80,51%)0,066 ASA1 273 (0,17%)51 (0,08%)< 0,0013 (0,05%)2 (0,07%)0,658 ASA2 26,600 (16,86%)10,525 (15,86%)< 0,001272 (4,18%)121 (3,96%)0,601 ASA3 126,479 (80,14%)53,918 (81,25%)< 0,0015406 (83,17%)2504 (81,88%)0,121 ASA4 4508 (2,86%)1886 (2,84%)0,851817 (12,57%)430 (14,06%)0,043 ASA5 13 (0,01%)5 (0,01%)0,8652 (0,03%)1 (0,03%)1,000 White 108,539 (68,78%)45,844 (69,08%)0,1523950 (60,77%)1862 (60,89%)0,911 Black 26,402 (16,73%)12,166 (18,33%)< 0,0011800 (27,69%)886 (28,97%)0,194 Other 22,932 (14,53%)8425 (12,70%)< 0,001750 (11,54%)310 (10,14%)0,042 Smokers 6491 (4,11%)2513 (3,79%)< 0,001234 (3,60%)100 (3,27%)0,413 Diabetes 40,011 (25,35%)16,842 (25,38%)0,0881698 (26,12%)765 (25,02%)0,114 Steroid/immunosupressive use 4444 (2,82%)1979 (2,98%)0,031202 (3,11%)108 (3,53%)0,275 COPD 1476 (0,94%)692 (1,04%)0,01860 (0,92%)46 (1,50%)0,011 History of PE 2328 (1,48%)958 (1,44%)0,571131 (2,02%)60 (1,96%)0,862 Sleep apnea 46,603 (29,53%)18,386 (27,71%)< 0,0011835 (28,23%)832 (27,21%)0,298 GERD 67,277 (42,63%)29,657 (44,69%)< 0,0012136 (32,86%)1117 (36,53%)< 0,001 Previous surgery 34,034 (21,57%)15,136 (22,81%)< 0,0011339 (20,60%)610 (19,95%)0,460 Previous PCI/PTCA 2049 (1,30%)815 (1,23%)0,17761 (0,94%30 (0,98%)0,842 Previous cardiac surgery 1349 (0,85%)561 (0,85%)0,82542 (0,65%)20 (0,65%)0,964 Heart failure 797 (0,51%)494 (0,74%)< 0,00171 (1,09%)41 (1,34%)0,292 Ventricular assist device 549 (0,35%)259 (0,39%)0,12636 (0,55%)20 (0,65%)0,567 Hypertension 53,228 (33,73%)21,412 (32,27%)< 0,0011671 (25,17%)826 (27,01%)0,176 Hyperlipidemia 41,362 (26,21%)18,250 (27,50%)< 0,0011564 (24,06%)764 (24,98%)0,327 History of DVT 11,259 (7,13%)5190 (7,82%)< 0,001808 (12,43%)376 (12,30%)0,852 Anticoagulatic therapy 4235 (2,68%)1695 (2,55%)0,082208 (3,20%)100 (3,27%)0,856 Venous stasis 1905 (1,21%)800 (1,21%)0,975140 (2,15%)60 (1,96%)0,541 IVC filter 599 (0,38%)249 (0,38%)0,87953 (0,82%)20 (0,65%)0,398 Dialysis 377 (0,24%)177 (0,27%)0,22620 (0,31%)9 (0,29%)0,912 Renal insufficiency 754 (0,48%)351 (0,53%)0,11427 (0,42%)15 (0,49%)0,604 Population characteristics. Comparing patients between LRYGB and RRYGB divided into two groups of BMI < 60 kg/m2 and BMI ≥ 60 kg/m2 The average age in group with BMI < 60 kg/m2 was higher than in the group with BMI ≥ 60 kg/m2 (45 vs. 40 years old, p < 0,001). Most of the patients were female (84,81% in BMI < 60 kg/m2 group, 79,30% in BMI ≥ 60 kg/m2 group) and white (68,87% in BMI < 60 kg/m2 group, 60,81% in BMI ≥ 60 kg/m2). In the BMI < 60 kg/m2 group, there was a significantly statistical difference between LRYGB and RRYGB in the variables: age, sex, ASA1-3, race: black and other, smoking, steroid use, COPD, sleep apnea, GERD, previous surgery, heart failure, hypertension, hyperlipidemia and history of DVT. In the BMI ≥ 60 kg/m2 group the significant difference between LRYGB and RRYGB were in other race, COPD and GERD. The entire specifics of the population are in Table 1. The aim of this study is determining the outcomes for patients with obesity class V comparing LRYGB and RRYGB. As there was no much difference in the BMI ≥ 60 kg/m2 population we decided not to do propensity score matching (PSM). Surgical outcomes In the second analysis we compared outcomes for LRYGB and RRYGB for all the patients and then separately for the group with BMI < 60 kg/m2 and BMI ≥ 60 kg/m2. In the BMI < 60 kg/m2 group there was significant difference between LRYGB and RRYGB in average operating time (121,23 ± 57,89 vs. 150,17 ± 61,78, p < 0,001), perioperative complications (4,79% vs. 4,44%, p < 0,001), surgical site infection (1,28% vs. 0,95%, p < 0,001), blood transfusion (1,06% vs. 0,80%, p < 0,001), GI tract bleeding (0,78% vs. 0,69%, p = 0,018), bowel obstruction (0,97% vs. 1,15%, p < 0,001), 30-day readmission rate (4,96% vs. 5,41%, p < 0,001) and LOS (1,54 ± 1,42 vs. 1,51 ± 1,66, p < 0,001). Moreover, in the RRYGB group a drain was used twice as often (6,81% vs. 15,62%, p < 0,001) but anastomosis was checked less frequently (94,33% vs. 91,98%, p < 0,001). In the BMI ≥ 60 kg/m2 group there was not many differences between LRYGB and RRYGB. Apart from the less frequently inserted drain in RRYGB group (8,56% vs. 22,34%, p < 0,001) as compared to LRYGB, there was longer average operating time (149,46 ± 61,02 vs. 120,97 ± 57,64, p < 0,001), more frequent leak checks (93,89% vs. 91,61%, p < 0,001) and shorter length of stay (1,57 ± 1,79 vs. 1,69 ± 1,98, p < 0,001). There was no other differences between LRYGB and RRYGB in the BMI ≥ 60 kg/m2 group (Table 2.). Table 2Comparing outcomes between LRYGB and RRYGB in patients with BMI < 60 kg/m2 and BMI ≥ 60 kg/m2BMI < 60 kg/m2BMI ≥ 60 kg/m2LRYGB, n = 157,873%RRYGB, n = 66,385% p LRYGB, n = 6508%RRYGB, n = 3062% p Average operating time (min) 121,23 ± 57,89150,17 ± 61,78< 0,001120,97 ± 57,64149,46 ± 61,02< 0,001 Anastamosis checked 145,21491,98%62,61894,33%< 0,001596291,61%287593,89%< 0,001 Drain placed 24,65915,62%45186,81%< 0,001145422,34%2628,56%< 0,001 Perioperative complications 75704,79%29454,44%< 0,0013415,24%1605,23%0,977 SSI 20151,28%6300,95%< 0,0011031,58%351,14%0,092 Leak 4580,29%2110,32%0,272240,37%70,23%0,260 Wound disruption 1120,07%430,06%0,61280,12%30,10%0,737 Pneumonia 3830,24%1710,26%0,852160,25%90,29%0,810 Unplanned intubation 1770,11%850,13%0,673110,17%60,20%0,891 Pulmonary embolism 1870,12%910,14%0,58980,12%60,20%0,572 On ventilator > 48 h 1680,11%860,13%0,137100,15%50,16%1,000 Progressive renal insufficiency 740,05%410,06%0,155100,15%40,13%1,000 Acute renal failure 1030,07%440,07%0,93070,11%70,23%0,159 UTI 7390,47%2980,45%0,541320,49%210,69%0,233 Cardiac arrest 790,05%430,06%0,17280,12%70,23%0,268 Blood transfusion 16721,06%5330,80%< 0,001590,91%270,88%1,000 Sepsis 2710,17%1230,19%0,482100,15%80,26%0,257 Unplanned admission ICU 11860,75%4850,73%0,604630,97%331,08%0,615 GI tract bleeding 12340,78%4560,69%0,018580,89%280,91%0,911 Bowel obstruction 15300,97%7621,15%< 0,001580,89%230,75%0,485 ED visits 30-day 17,00610,77%731311,02%0,09078712,09%37912,38%0,691 Readmission 30-day 78284,96%35935,41%< 0,0013565,47%1815,91%0,382 Reoperation 30-day 30061,90%12981,96%0,4201121,72%601,96%0,413 Interventions 30-day 22921,45%9591,44%0,896921,41%461,50%0,734 Deaths 30-day 1400,09%650,10%0,509110,17%60,20%0,770 LOS (days) 1,54 ± 1,421,51 ± 1,66< 0,0011,69 ± 1,981,57 ± 1,79< 0,001 Comparing outcomes between LRYGB and RRYGB in patients with BMI < 60 kg/m2 and BMI ≥ 60 kg/m2 A third analysis was conducted comparing patients with BMI < 60 kg/m2 to patients with BMI ≥ 60 kg/m2depending on the type of surgery. Patient with BMI ≥ 60 kg/m2 in the RRYGB group were more likely to have preoperative complications (5,23% vs. 4,44%, p = 0,039), acute renal failure (0,23% vs. 0,07%, p = 0,007), cardiac arrest (0,023% vs. 0,06%, p = 0,006), bowel obstruction (1,15% vs. 0,75%, p = 0,042), unplanned admission to ICU (1,08% vs. 0,73%, p = 0,029) and Emergency Department visits after discharge (12,38% vs. 11,02%, p = 0,019) in compare to patients with BMI < 60 kg/m2. There was no significant difference in operating time but patients with BMI ≥ 60 kg/m2 stayed longer in a hospital (1,57 ± 1,79 vs. 1,51 ± 1,66, p = 0,004) (Table 3). Table 3Comparing outcomes of two groups of patients with BMI < 60 kg/m2 or BMI ≥ 60 kg/m2 who underwent either LRYGB or RRYGBLaparoscopic RYGBRobotic RYGBBMI < 60 kg/m2, n = 157,873%BMI ≥ 60 kg/m2, n = 6508% p BMI < 60 kg/m2, n = 66,385%BMI ≥ 60 kg/m2, n = 3062% p Average operating time (min) 121,23 ± 57,89120,97 ± 57,640,956150,17 ± 61,66149,46 ± 61,020,813 Anastamosis checked 145,21491,98%596291,61%0,11762,61894,33%287593,89%0,140 Drain placed 24,65915,62%145422,34%< 0,00145186,81%2628,56%< 0,001 Perioperative complications 75704,79%3415,24%0,10029454,44%1605,23%0,039 SSI 20151,28%1031,58%0,0326300,95%351,14%0,281 Leak 4580,29%240,37%0,2502110,32%70,23%0,388 Wound disruption 1120,07%80,12%0,151430,06%30,10%0,485 Pneumonia 3830,24%160,25%0,9541710,26%90,29%0,699 Unplanned intubation 1770,11%110,17%0,181850,13%60,20%0,299 Pulmonary embolism 1870,12%80,12%0,915910,14%60,20%0,325 On ventilator > 48 h 1680,11%100,15%0,256860,13%50,16%0,603 Progressive renal insufficiency 740,05%100,15%< 0,001410,06%40,13%0,136 Acute renal failure 1030,07%70,11%0,212440,07%70,23%0,007 UTI 7390,47%320,49%0,7852980,45%210,69%0,058 Cardiac arrest 790,05%80,12%0,022430,06%70,23%0,006 Blood transfusion 16721,06%590,91%0,2385330,80%270,88%0,633 Sepsis 2710,17%100,15%0,7301230,19%80,26%0,343 Unplanned admission ICU 11860,75%630,97%0,0484850,73%331,08%0,029 GI tract bleeding 12340,78%580,89%0,3274560,69%280,91%0,139 Bowel obstruction 15300,97%580,89%0,5297621,15%230,75%0,042 ED visits 30-day 17,00610,77%78712,09%< 0,001731311,02%37912,38%0,019 Readmission 30-day 78284,96%3565,47%0,06335935,41%1815,91%0,234 Reoperation 30-day 30061,90%1121,72%0,28912981,96%601,96%0,987 Interventions 30-day 22921,45%921,41%0,8019591,44%461,50%0,794 Deaths 30-day 1400,09%110,17%0,036650,10%60,20%0,134 LOS (days) 1,54 ± 1,421,69 ± 1,98< 0,0011,51 ± 1,661,57 ± 1,790,004 Comparing outcomes of two groups of patients with BMI < 60 kg/m2 or BMI ≥ 60 kg/m2 who underwent either LRYGB or RRYGB In the fourth analysis, we compared LRYGB and RRYGB in patients with BMI ≥ 60 kg/m2 depending on ASA score. Besides the average operating time (in patients with ASA I-V), anastomosis checks (only in patients with ASA III), drain placed (in patients with ASA I-V), and length of stay (in patients with ASA I-V), there was no significant difference between LRYGB and RRYGB in patients with BMI ≥ 60 kg/m2 and diverse ASA score. Only in patients with BMI ≥ 60 kg/m2 with ASA IV/V the rate of unplanned admission to intensive care unit was significantly lower in robotic group (0,046% vs. 1,83%, p = 0,047). To see if there was any difference between LRYGB and RRYGB in patients with BMI ≥ 60 kg/m2 over the years we performed analysis, where we analyzed every year separately. The biggest difference was in average operating time in the RRYGB which was 160,31 ± 68,42 min in 2020 and 141,89 ± 58,40 min in 2023, but the shortening of procedure time was not statically significant (p = 0,238). There was no significant difference in outcomes between LRYGB and RRYGB in patients with BMI ≥ 60 kg/m2 besides operating time and LOS over the years. Discussion Roux-en-Y gastric bypass (RYGB) is one of the most performed bariatric surgeries, combining restrictive and malabsorptive components. In the study by Nasser H. et al. LRYGB as compared to other bariatric operations was associated with significant weight loss and medication discontinuation one year following surgery [16]. In addition, there were beneficial outcomes for patients with multiple diseases associated with their obesity. In a different study by Thaher O. et al. the improvement in hypertension and GERD was significantly in favor of the RYGB [4]. In patients with obesity class V (BMI ≥ 60 kg/m²), the RYGB procedure is an effective tool for reducing weight and improving metabolic parameters. The laparoscopic RYGB have been proved to be safe as well as laparoscopic sleeve gastrectomy [3]. However, it is technically a more complex operation, especially in patients with massive visceral fat and massive abdominal walls. Robotic surgery offers potential advantages in this group of patients, particularly in terms of precision and ergonomics of the operation. This study involving RYGB patients is, to our knowledge, the first to describe this population using the MBSAQIP 2020–2023 database. We compared patients with BMI < 60 kg/m2 and BMI ≥ 60 kg/m2 who underwent either laparoscopic or robotic RYGB. We also compared the outcomes for patients with obesity class V comparing LRYGB and RRYGB. The fact that there are statistically significant differences in the group with BMI < 60 kg/m2 that don’t show in the group with BMI ≥ 60 kg/m2 is probably due to the much smaller sample size of the latter group, as well as differences in the groups in terms of age, gender, and, notably, BMI. Our study showed that patients with BMI ≥ 60 kg/m2 are at higher risk of perioperative complications, acute renal failure, cardiac arrest, unplanned admission to ICU and Emergency Department visits after discharge as compared to patients with BMI < 60 kg/m2. There was no significant difference in operating time, but patients with BMI ≥ 60 kg/m2 experienced prolonged hospitalization. These results are consistent with the available data, where patients with a BMI ≥ 60 kg/m2 are the most likely to experience any perioperative complications [17]. In the study by Kauffels A. et al. complication rates and length of hospital stay did not significantly differ between patients with BMI ≥ 50 kg/m2 comparing to patients with BMI < 50 kg/m2 after RRYGB [18]. The sample was small including 72 people to group with BMI ≥ 50 kg/m2 and 41 patients to the group with BMI < 50 kg/m2. The incidence of any complications was one in each group which may be the reason of different results. In another study by Wesley Vosburg R. et al., which was also based on MBSAQIP database, the results of RRYGB showed lower infectious complications and blood transfusions [19]. In our study, these variables were significant only in the group with BMI < 60 kg/m2. There was no significant difference in postoperative outcomes in patients with BMI ≥ 60 kg/m2. In second analysis we evaluated and compared outcomes of LRYGB and RRYGB for patients with BMI ≥ 60 kg/m2 and the results showed no significant differences in postoperative outcomes except the shorter length of stay, longer operating time, more frequent anastomosis checks and less placement of drains in the robotic group. The fact that there are not many statistically significant differences in the group BMI ≥ 60 kg/m2 can be caused due to the small sample size and greater homogeneity of this group. These differences can be also attributed to the surgeons’ experience and preferences, as well as the characteristics of the robotic platform. Robotic surgery offers many advantages, such as three-dimensional imaging, increased precision, and facilitated delicate movements in small spaces. Improved visualization, the precise suturing and the new robotic staplers may be the influence the decision not to insert a drain (in our study the drain was inserted 3 times less often in the robotic group (8,56% vs. 22,34%, p < 0,001)). However, this doesn’t have the impact in clinical practice. Our findings are similar to the study performed by Marincola G. et al., where intraoperative and post-operative complication rates and were comparable between the groups with robotic and laparoscopic approach in patients with BMI ≥ 50 kg/m2 [20]. The study also showed longer operative time in robotic RYGB. Systematic review and meta-analysis conducted by Lang Y. et al. including 28 studies with over 82,000 patients, showed no different between robotic versus laparoscopic gastric bypass in terms of the complication rate, length of stay and operative time [21]. These results may be caused due to group heterogeneity and therefore differ from the results of our study. In a different MBSAQIP database study Sebastian R. et al. confirmed there was no statistical difference for the outcomes for RRYGB vs. LRYGB, except the fewer requirements for blood transfusions [22]. This may be the result of including in the analysis patients with variety of BMIs. In analysis 4 we compared LRYGB and RRYGB in patients with BMI ≥ 60 kg/m2 despite ASA score. Only in patients with BMI ≥ 60 kg/m2 with ASA IV/V the rate of unplanned admission to intensive care unit was significantly lower in robotic group (0,046% vs. 1,83%, p = 0,047). This may be the result of qualifying patients with a multicomorbidities and higher risk factors in favor for laparoscopic procedures. On the other hand, the study cited earlier shows similar results in complication rates between patients with potential risk factors (higher ASA score) [18]. Moreover Fantola G. et al. in their review showed that robotic approach in revisional surgery is safe and effective [23]. In addition, more robotic platforms provide better visualization and precision, which can be useful in revision procedures [22, 24]. In the last analysis we compared LRYGB and RRYGB in patients with BMI ≥ 60 kg/m2 over the years. The most significant difference was in average operating time in robotic RYGB which was 160,31 ± 68,42 min in 2020 and 141,89 ± 58,40 min in 2023, but this finding was not statically significant. Such finding suggests that learning curve continues to progress. Kauffels A. et al. investigated the learning curve in robotic RYGB [25]. The average time for procedure from 1 to 10 was 171.2 ± 26.3 min versus procedure 63–72: 116.0 ± 10.9 min. The learning curve stabilization was observed after 30 procedures for the surgeon. Besides the great number of included patients, well-thought-out study groups and statistics there are also limitations of this study. It is a retrospective study based on MBSAQIP database. This database offers many opportunities but also comes with some limits, e.g., recall and record bias. The MBSAQIP database provides postoperative data only up to 30 days, some of the data were missing or incomplete, the robotic approach is specially extended since 2020 but the robotic platform is not specified, which also may influence the results. Other significant factors as psychological aspects, prehabilitation were not measured. The collection of data cannot by influenced by researchers and may be performed by non-medical assistants which limits in internal validity and misclassification bias. Conclusions Patients with BMI ≥ 60 kg/m2 have higher rates of complications compared to patients with BMI < 60 kg/m2 after RRYGB. RRYGB seems to be safe method to perform in patients with BMI ≥ 60 kg/m2 with no difference in 30-day complication rate between laparoscopic and robotic RYGB, still longer average operating time but shorter length of stay. No additional analysis found significant differences between laparoscopic and robotic RYGB in patients with BMI ≥ 60 kg/m2. There is still need for good quality multi-centre prospective research to define the best approach in patients with BMI ≥ 60 kg/m2. Author contributions K.R., J.S., R.A.F. and T.R wrote the main manuscript text. K.R. and J.S. prepared Tables 1, 2, 3. K.R. and T.R. prepared the abstract. All authors reviewed the manuscript. Data availability Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP). Declarations Conflict of interest Authors declare that they have no conflict of interest. The manuscript has not been submitted to more than one journal for simultaneous consideration. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP).